Delisting risk
Lucid Diagnostics
Commercializes EsoGuard testing on esophageal cells collected with EsoCheck.
$1.00
After-hours close+0.00 (+0.36%)
At close$0.9964(+1.26%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 18.67%35.62M sharesInsiders 6.05%11.54M sharesOther 75.28%143.62M shares
Shares outstanding 190.77M · Float 140.58M · 73.7% free float
Institutions13F, as of Mar 31, 2026
103 holders · 35.62M shares · 26 new positions · 58 increased · 19 reduced · 12 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 4.64M | 2.43% | +325.6K | May 13, 2026 |
| Vanguard Capital Management LLC | 4.15M | 2.18% | +4.15Mnew | May 15, 2026 |
| Masters Capital Management LLC | 4.00M | 2.10% | 0 | May 15, 2026 |
| Abrdn PLC | 3.64M | 1.91% | +186.4K | Apr 29, 2026 |
| Two Seas Capital LP | 3.00M | 1.57% | 0 | May 15, 2026 |
| Geode Capital Management, LLC | 2.25M | 1.18% | +218.5K | May 15, 2026 |
| Russell Investments Group, Ltd. | 1.58M | 0.83% | +1.57M | May 8, 2026 |
| State Street Corp | 1.55M | 0.81% | +201.6K | May 15, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| PAVmed Inc. | 27.50% | 38.82M | 13D | Feb 9, 2026 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Lishan Aklog | director, officer: Chief Executive Officer | 3.64M | 1.91% | Feb 24, 2026 |
| Dennis M. Mcgrath | officer: Chief Financial Officer | 1.81M | 0.95% | Feb 24, 2026 |
| Shaun O'Neil | officer: President and COO | 1.45M | 0.76% | Feb 24, 2026 |
| Dennis Matheis | director | 1.03M | 0.54% | May 21, 2026 |
| Michael Adam Gordon | officer: General Counsel and Secretary | 1.00M | 0.52% | Feb 24, 2026 |
| Victoria Tou-ho Lee | officer: Chief Medical Officer | 650.0K | 0.34% | Apr 13, 2026 |
| James L. Cox | director | 405.1K | 0.21% | Feb 24, 2026 |
| John R. Palumbo | director | 338.0K | 0.18% | Feb 24, 2026 |
| Stanley Lapidus | director | 337.4K | 0.18% | Feb 24, 2026 |
| Jacque J. Sokolov | director | 320.5K | 0.17% | Feb 24, 2026 |
1 ten-percent owner holds 31.30M shares by Form 4, outside the officers-and-directors figure above · 2 people have not refiled in the last 18 months (453.6K shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| May 20, 2026 | Dennis Matheisdirector | Purchase | 245,000 | $1.00 | 1,033,443 |
CongressHouse and Senate disclosures
Not reported.